MedTrace Logo

Identification of Novel Molecular Markers for Vasospasm

NCT02389634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-04-19

No results posted yet for this study

Summary

The purpose of the study is to identify novel genetic and protein markers for the process of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Conditions

  • Cerebral Vasospasm
  • Subarachnoid Hemorrhage

Sponsors & Collaborators

  • Translational Genomics Research Institute

    collaborator OTHER

  • St. Joseph's Hospital and Medical Center, Phoenix

    lead OTHER

Principal Investigators

  • Robert F Spetzler, MD · Saint Joseph's Hospital and Medical Center/Barrow Neurological Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2019-10-25
Completion
2019-10-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02389634 on ClinicalTrials.gov